Stroke Prevention in Atrial Fibrillation.
10.18501/arrhythmia.2017.022
- Author:
Myung Jin CHA
1
Author Information
1. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. chamj81@gmail.com
- Publication Type:Review
- Keywords:
Atrial Fibrillation;
Stroke;
Anticoagulation
- MeSH:
Anticoagulants;
Atrial Fibrillation*;
Female;
Heart Valves;
Hemorrhage;
Humans;
Male;
Mass Screening;
Mitral Valve Stenosis;
Stroke*;
Vitamin K
- From:International Journal of Arrhythmia
2017;18(3):137-142
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
It is important to evaluate the risks of stroke and bleeding when screening patients with atrial fibrillation (AF), in whom anticoagulation therapy is indicated. Oral anticoagulation therapy is recommended in male AF patients with CHA₂DS₂-VASc score ≥1 and female AF patients with CHA₂DS₂-VASc score ≥2. Non-vitamin K oral anticoagulants (NOACs) are preferred over vitamin K anticoagulants in eligible patients. NOACs are contraindicated in patients with mechanical heart valves or moderate-to-severe mitral stenosis.
